-
PublishedApril 18, 2022
Expansion of Good Samaritan Law gets bipartisan backing, but may face a veto
The Mills administration has supported a more modest expansion of the law, which would protect certain people from arrest if someone reports a potentially fatal overdose.
-
PublishedMarch 10, 2022
‘Scum of the earth’: Opioid victims face owners of Purdue Pharma
Addiction and overdose survivors and those who have lost loved ones have unleashed their emotions on members of the family they blame for fueling the opioid epidemic.
-
PublishedMarch 3, 2022
Purdue Pharma, U.S. states agree to new opioid settlement
The plan could be worth more than $10 billion over time and calls for members of the Sackler family to give up control of the company so it can be turned into a new entity with profits used to fight the opioid crisis.
-
PublishedFebruary 22, 2022
Gov. Mills barely mentioned opioid crisis in State of the State, and people noticed
Although the governor's speech drew some criticism, administration officials say they're focused on the epidemic of fatal overdoses and making systemic changes to improve services and save lives.
-
PublishedFebruary 1, 2022
Native American tribes reach landmark opioid settlement
All federally recognized tribes will be able to participate in the settlements, even if they did not sue over opioids.
-
PublishedDecember 12, 2021
Waterville sets special meeting to vote on employee bonuses
The City Council is scheduled to meet via Zoom at 6 p.m. Monday. Those wanting to tune in can watch the meeting through a link on the city's website — www.waterville-me.gov.
-
PublishedNovember 23, 2021
Jury holds CVS, Walgreens, Walmart responsible for role in Ohio opioid crisis
This was the first time pharmacy companies had completed a trial to defend themselves in a drug crisis that has killed a half-million Americans over the past 2 decades.
-
PublishedNovember 11, 2021
Federal agents charge 13 people in New England drug trafficking pipeline
The crackdown targeted a Massachusetts-based gang that moved drugs and counterfeit pills into Maine and New Hampshire.
-
PublishedNovember 10, 2021
Maine health clinics to develop low barrier opioid use disorder treatment program
Maine health clinics are participating in a 12-month pilot program to develop and maintain low-barrier opioid use disorder treatment programs.
-
PublishedSeptember 2, 2021
Deal with OxyContin maker leaves families angry, conflicted
A landmark settlement in the nation’s opioid epidemic is forcing the owners of OxyContin maker Purdue Pharma to give up the company and pay out $4.5 billion.
- ← Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- Next Page →